StonvexLoading…
StonvexStonvexStonvexCore line items from SMG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $3.41B | $3.55B | $3.55B | $3.92B |
Operating Income | $358.60M | $208.80M | $-174.40M | $-434.00M |
Net Income | $145.20M | $-34.90M | $-380.10M | $-437.50M |
EPS (Diluted) | $2.47 | $-0.61 | $-6.79 | $-7.88 |
Total Assets | $2.74B | $2.87B | $3.41B | $4.30B |
Total Liabilities | $3.10B | $3.26B | $3.68B | $4.15B |
Cash & Equivalents | $36.60M | $71.60M | $31.90M | $86.80M |
Free Cash Flow OCF − CapEx | $273.90M | $583.50M | $438.20M | $-242.50M |
Shares Outstanding | 57.80M | 57.10M | 56.50M | 55.50M |